Stocks and Investing Stocks and Investing
Tue, November 23, 2021
[ 12:00 AM ] - WOPRAI
Matt VanVliet Maintained (ZM) at Strong Buy with Decreased Target to $400 on, Nov 23rd, 2021
[ 12:00 AM ] - WOPRAI
Matthew Nikam Maintained (ZM) at Hold with Decreased Target to $280 on, Nov 23rd, 2021
[ 12:00 AM ] - WOPRAI
Peter Levine Maintained (ZM) at Hold with Decreased Target to $235 on, Nov 23rd, 2021
[ 12:00 AM ] - WOPRAI
Nikolay Beliov Downgraded (ZM) to Hold and Decreased Target to $270 on, Nov 23rd, 2021
[ 12:00 AM ] - WOPRAI
Walter Pritchard Maintained (ZM) at Hold with Decreased Target to $250 on, Nov 23rd, 2021
[ 12:00 AM ] - WOPRAI
Puneet Souda Maintained (A) at Buy with Increased Target to $175 on, Nov 23rd, 2021
[ 12:00 AM ] - WOPRAI
Daniel Arias Maintained (A) at Hold with Increased Target to $169 on, Nov 23rd, 2021
[ 12:00 AM ] - WOPRAI
Dan Brennan Maintained (A) at Buy with Increased Target to $187 on, Nov 23rd, 2021
[ 12:00 AM ] - WOPRAI
Derik De Bruin Maintained (A) at Strong Buy with Increased Target to $179 on, Nov 23rd, 2021
[ 12:00 AM ] - WOPRAI
Samik Chatterjee Maintained (AAPL) at Buy and Held Target at $180 on, Nov 23rd, 2021
[ 12:00 AM ] - WOPRAI
Justin Smith Upgraded (ABBV) to Strong Buy and Held Target at $172 on, Nov 23rd, 2021
[ 12:00 AM ] - WOPRAI
Adam Samuelson Initiated (BHIL) at Hold and Held Target at $315 on, Nov 23rd, 2021
[ 12:00 AM ] - WOPRAI
Peter Keith Initiated (AIRS) at Buy and Held Target at $22 on, Nov 23rd, 2021
[ 12:00 AM ] - WOPRAI
Whit Mayo Initiated (AIRS) at Buy and Held Target at $26 on, Nov 23rd, 2021
[ 12:00 AM ] - WOPRAI
Simeon Gutman Initiated (AIRS) at Buy and Held Target at $17 on, Nov 23rd, 2021
[ 12:00 AM ] - WOPRAI
John Ransom Initiated (AIRS) at Buy and Held Target at $18 on, Nov 23rd, 2021
[ 12:00 AM ] - WOPRAI
Gary Mobley Maintained (ADI) at Hold with Increased Target to $185 on, Nov 23rd, 2021
[ 12:00 AM ] - WOPRAI
Mani Foroohar Maintained (ARWR) at Hold with Increased Target to $45 on, Nov 23rd, 2021
Mon, November 22, 2021
[ 12:00 AM ] - WOPRAI
Scott Graham Initiated (AOS) at Strong Buy and Held Target at $100 on, Nov 22nd, 2021
[ 12:00 AM ] - WOPRAI
Stephen Byrd Maintained (AEE) at Hold with Decreased Target to $86 on, Nov 22nd, 2021
[ 12:00 AM ] - WOPRAI
Stephen Byrd Maintained (AEP) at Buy with Decreased Target to $105 on, Nov 22nd, 2021
[ 12:00 AM ] - WOPRAI
Peter Sazel Upgraded (ADBE) to Buy and Increased Target to $820 on, Nov 22nd, 2021
[ 12:00 AM ] - WOPRAI
Hans Mosesmann Initiated (AIP) at Strong Buy and Held Target at $35 on, Nov 22nd, 2021
[ 12:00 AM ] - WOPRAI
Gus Richard Initiated (AIP) at Buy and Held Target at $27 on, Nov 22nd, 2021
[ 12:00 AM ] - WOPRAI
Mark Lipacis Initiated (AIP) at Strong Buy and Held Target at $33 on, Nov 22nd, 2021
[ 12:00 AM ] - WOPRAI
Ambrish Srivastava Initiated (AIP) at Hold and Held Target at $24 on, Nov 22nd, 2021
[ 12:00 AM ] - WOPRAI
Gabe Daoud Downgraded (BLNK) to Hold and Decreased Target to $40 on, Nov 22nd, 2021
[ 12:00 AM ] - WOPRAI
Joseph Schwartz Maintained (BMRN) at Buy with Increased Target to $115 on, Nov 22nd, 2021
[ 12:00 AM ] - WOPRAI
Tim Lugo Upgraded (BMRN) to Buy on, Nov 22nd, 2021
[ 12:00 AM ] - WOPRAI
Matthew Harrison Maintained (BMRN) at Hold with Increased Target to $90 on, Nov 22nd, 2021

Matthew Harrison Maintained (BMRN) at Hold with Increased Target to $90 on, Nov 22nd, 2021


Published on 2024-10-27 18:45:08 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Hold with Increased Target from $82 to $90 on, Nov 22nd, 2021.

Matthew has made no other calls on BMRN in the last 4 months.



There are 2 other peers that have a rating on BMRN. Out of the 2 peers that are also analyzing BMRN, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Kennen MacKay of "RBC Capital" Maintained at Hold with Increased Target to $88 on, Thursday, July 29th, 2021


This is the rating of the analyst that currently disagrees with Matthew

  • Paul Matteis of "Stifel" Upgraded from Hold to Strong Buy and Increased Target to $96 on, Thursday, September 9th, 2021
Contributing Sources